HUBUNGAN TINGKAT KEPATUHAN KONSUMSI OBAT KELASI BESI DENGAN KADAR FERRITIN PADA PASIEN THALASSEMIA ANAK DI RSUD DR. MOEWARDI

Tabita Desna Shadiar  Hawa; Muhammad  Riza; Diah Lintang  Kawuryan

doi:10.47701/infokes.v13i1.2533

Authors

Tabita Desna Shadiar Hawa Universitas Sebelas Maret
Muhammad Riza Universitas Sebelas Maret
Diah Lintang Kawuryan Universitas Sebelas Maret

DOI:

https://doi.org/10.47701/infokes.v13i1.2533

Keywords:

Thalassemia, obat kelasi besi, kadar ferritin, kepatuhan minum obat

Abstract

Thalassemia is a hereditary hemolytic disease caused by mutations in the hemoglobin synthesis chain. Transfusion-dependent thalassemia patients require iron chelation therapy to prevent complications of iron overload. Adherence with regular iron chelation consumption is important for good survival, reducing morbidity and mortality in thalassemia patients. This research is an analysis of an observational study with a cross-sectional approach. This research was conducted at RSUD Dr. Moewardi. The subjects of this study were pediatric thalassemia patients who were taking deferiprone iron chelating drugs. The sample was taken using purposive sampling method, by analysing medical record data and the MMAS-8 questionnaire. Data were examined using the chi-square test with the SPSS application. Results: There were 56 subjects to be analyzed consisting of 23 males and 33 females. Based on the chi-square test, there was a significant relationship between consumption of iron chelating drugs and ferritin levels with p = 0.026. In addition, another study was conducted using the chi-square test regarding nutritional status and duration of thalassemia illness on ferritin levels. The results obtained were p value = 0.977 for the relationship between nutritional status and p value = 0.977 for the long duration of thalassemia illness. It can be concluded that both of them have no significant effect on ferritin levels. Adherence with taking iron chelating drugs has a significant relationship to ferritin levels in thalassemia patients.

Downloads

Download data is not yet available.

References

Agustina R, Mandala Z, Liyola R. Jurnal Ilmiah Kesehatan Sandi Husada Kadar Ferritin dengan Status Gizi Pasien Thalassemia β Mayor Anak di RSAM Bandar Lampung Pendahuluan. J Ilm Kesehat Sandi Husada. 2020;11(1):219–24.

Husna N, Arif A Al, Putri C, Leonard E, Handayani NSN. Prevalence and Distribution of Thalassemia Trait Screening. J thee Med Sci (Berkala Ilmu Kedokteran). 2017;49(03):106– 13.

Trianisya R, Akbar IB. Kepatuhan Terapi Kelasi Besi Berdasarkan Kadar Feritin pada Penderita Thalassemia di Rumah Sakit Syamsudin Kota Sukabumi. 2015;690–4.

Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, et al. Thalassemia, a human blood disorder. Brazilian J Biol.2021;83:1–8.

Gustiana H, Gunantara T, Rathomi HS. Kepatuhan Konsumsi Obat Kelasi Besi dan Kadar Serum Feritin Pasien Talasemia Beta-Mayor di RSUD Al- Ihsan Bandung. J Integr Kesehat Sains. 2020;2(1):26–30.

Angastiniotis M, Lobitz S. Thalassemias: An overview. Int J Neonatal Screen. 2019;5(1):1–11.

Saliba AN, Harb AR, Taher AT. Iron chelation therapy in transfusion- dependent thalassemia patients: Current strategies and future directions. J Blood Med. 2015;6:197– 209.

Nabila A, Puspitasari CE, Erwinayanti GA. S. Jurnal Sains dan Kesehatan. J Sains dan Kesehat. 2020;3(1):242–7.

Sukhmani Sidhu, Shruti Kakkar PD. Adherence to Iron Chelation Therapy and Its. 2021;15(1).

Chawsamtong S, Jetsrisuparb A, Kengkla K, Jaisue S. Effect of drug use calendar on adherence to iron chelation therapy in young thalassemia patients. Pharm Pract (Granada). 2022;20(1):1–7.

Rafika R, Marwoto D, Hayati L. Korelasi Antara Kadar Feritin Serum dan Status Gizi Pasien Talasemia-? Mayor. Biomed J Indones J Biomedik Fak Kedokt Univ Sriwij. 2019;5(2):88–93.

Putri SS, Suryati C, Nandini N. Jurnal Sains dan Kesehatan. J Sains dan Kesehat. 2020;3(1):242–7.